ALDX
Price
$2.66
Change
+$0.01 (+0.38%)
Updated
Apr 25 closing price
Capitalization
158.83M
3 days until earnings call
PLRX
Price
$1.46
Change
-$0.11 (-7.01%)
Updated
Apr 25 closing price
Capitalization
89.62M
14 days until earnings call
Ad is loading...

ALDX vs PLRX

Header iconALDX vs PLRX Comparison
Open Charts ALDX vs PLRXBanner chart's image
Aldeyra Therapeutics
Price$2.66
Change+$0.01 (+0.38%)
Volume$1.38M
Capitalization158.83M
Pliant Therapeutics
Price$1.46
Change-$0.11 (-7.01%)
Volume$653.42K
Capitalization89.62M
ALDX vs PLRX Comparison Chart
Loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALDX vs. PLRX commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a Buy and PLRX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (ALDX: $2.66 vs. PLRX: $1.46)
Brand notoriety: ALDX and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 71% vs. PLRX: 28%
Market capitalization -- ALDX: $158.83M vs. PLRX: $89.62M
ALDX [@Biotechnology] is valued at $158.83M. PLRX’s [@Biotechnology] market capitalization is $89.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 0 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • ALDX’s FA Score: 0 green, 5 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALDX and PLRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 4 TA indicator(s) are bullish while PLRX’s TA Score has 4 bullish TA indicator(s).

  • ALDX’s TA Score: 4 bullish, 7 bearish.
  • PLRX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PLRX is a better buy in the short-term than ALDX.

Price Growth

ALDX (@Biotechnology) experienced а +21.46% price change this week, while PLRX (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was -3.08%, and the average quarterly price growth was -10.41%.

Reported Earning Dates

ALDX is expected to report earnings on Aug 08, 2025.

PLRX is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALDX($159M) has a higher market cap than PLRX($89.6M). ALDX YTD gains are higher at: -46.693 vs. PLRX (-88.914). ALDX has higher annual earnings (EBITDA): -53.68M vs. PLRX (-205.16M). PLRX has more cash in the bank: 356M vs. ALDX (101M). ALDX has less debt than PLRX: ALDX (15.3M) vs PLRX (60.2M). ALDX (0) and PLRX (0) have equivalent revenues.
ALDXPLRXALDX / PLRX
Capitalization159M89.6M177%
EBITDA-53.68M-205.16M26%
Gain YTD-46.693-88.91453%
P/E RatioN/AN/A-
Revenue00-
Total Cash101M356M28%
Total Debt15.3M60.2M25%
FUNDAMENTALS RATINGS
ALDX: Fundamental Ratings
ALDX
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALDXPLRX
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
72%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
84%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
77%
MACD
ODDS (%)
Bullish Trend 4 days ago
88%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 5 days ago
76%
Declines
ODDS (%)
Bearish Trend 26 days ago
78%
Bearish Trend 21 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
81%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Ad is loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLLDY8.900.15
+1.72%
Sanlam Ltd.
TTDKY10.360.11
+1.07%
TDK Corp.
ELEMF1.07N/A
N/A
ELEMENTAL ALTUS ROYALTIES CORP.
SNNAF0.02N/A
N/A
SIENNA RESOURCES INC
PRNDY21.94-0.19
-0.86%
Pernod Ricard S.A.

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with CANF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then CANF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
+0.38%
CANF - ALDX
46%
Loosely correlated
-3.42%
CMVLF - ALDX
39%
Loosely correlated
N/A
CLLS - ALDX
39%
Loosely correlated
+1.32%
PLRX - ALDX
38%
Loosely correlated
-7.01%
ARVN - ALDX
37%
Loosely correlated
-0.98%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with LXRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then LXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
-7.01%
LXRX - PLRX
42%
Loosely correlated
+0.71%
ITRM - PLRX
41%
Loosely correlated
-3.08%
SRRK - PLRX
41%
Loosely correlated
-4.57%
FHTX - PLRX
40%
Loosely correlated
-2.46%
OCUL - PLRX
38%
Loosely correlated
-2.41%
More